Even, C., Wiedemann, A., Bargain, C., Dugage, M. R., Tourneau, C. L., Zurawski, S., Zurawski, G., Auperin, A., Codou, M., Savel, H., Centlivre, M., Villa-Languin, I., Abou-Lovergne, A., Lion, O., Thiébaut, R., Levy, Y., Gorphe, P. (2026). Randomized phase I/II trial adjuvant CD40.HVAC, an immunotherapy engaging dendritic cells (DC), in patients with HPV16+ oropharyngeal carcinoma (OPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6018